Derrick Ho Wai Siu (Derrick H W Siu, Ho Wai Derrick Siu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

Myasthenia Gravis

Placebo Controlled

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Derrick Ho Wai Siu, Frank Po-Yen Lin, Doah Cho, Sarah J Lord, Gillian Ziona Heller, R John Simes, Chee Khoon Lee
Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials. JCO precision oncology 8 (2024)
Lawrence Kasherman, Derrick Ho Wai Siu, Rachel Woodford, Carole A Harris
Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future. Cancers 14 (6) (2022)
Derrick Ho Wai Siu, Robert Sean O'Neill, Carole A Harris, Justine Wang, Luke Ardolino, Teesha D Downton, Matthew Tong, Jun Hee Hong, Venessa T Chin, Philip R Clingan, Morteza Aghmesheh, Hussein Soudy
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review. Immunotherapy 14 (7) (2022)
Derrick Ho Wai Siu, Niall Tebbutt, Lorraine Chantrill, Chris Karapetis, Christopher Steer, Kate Wilson, David Espinoza, Lisa Bailey, Sonia Yip, Jeff Cuff, Nick Pavlakis, Subotheni Thavaneswaran, Karen Briscoe, Ratnesh Srivastav, Jennifer Shannon, Eva Segelov, Jeannie Tie, Susan Caird, Alessandra Francesconi, Timothy Price, Melanie Wuttke, Rahul Ladwa, Katrin Sjoquist, Matthew Burge
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG). BMC cancer 21 (1) (2021)